XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
Total
Common stock
Additional Paid-in Capital
Contingently Issuable Common Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2020   48,943,082        
Beginning balances at Dec. 31, 2020 $ 120,785,000 $ 5,000 $ 395,491,000 $ 17,600,000 $ 0 $ (292,311,000)
Increase (decrease) in stockholders' equity [Roll Forward]            
Stock-based compensation 10,085,000   10,085,000      
Release of Block B Sponsor Earnout Shares from restriction (in shares)   859,000        
Issuance of contingently issuable common stock (in shares)   1,999,185        
Issuance of Contingently Issuable Common Stock     17,600,000 (17,600,000)    
Exercise of stock options (in shares)   123,837        
Exercise of stock options 1,074,000   1,074,000      
Exercise of warrants (in shares)   1,747,746        
Exercise of warrants 20,099,000   20,099,000      
Release of restricted stock units (in shares)   25,990        
Cancellation of shares used to settle payroll tax withholding 0          
Foreign currency translation adjustment 0          
Net loss (93,623,000)         (93,623,000)
Ending balances (in shares) at Sep. 30, 2021   53,698,840        
Ending balances at Sep. 30, 2021 58,420,000 $ 5,000 444,349,000 0 0 (385,934,000)
Beginning balances (in shares) at Jun. 30, 2021   53,353,858        
Beginning balances at Jun. 30, 2021 68,567,000 $ 5,000 436,372,000 0 0 (367,810,000)
Increase (decrease) in stockholders' equity [Roll Forward]            
Stock-based compensation 4,412,000   4,412,000      
Exercise of stock options (in shares)   36,660        
Exercise of stock options 318,000   318,000      
Exercise of warrants (in shares)   282,332        
Exercise of warrants 3,247,000   3,247,000      
Release of restricted stock units (in shares)   25,990        
Cancellation of shares used to settle payroll tax withholding 0          
Foreign currency translation adjustment 0          
Net loss (18,124,000)         (18,124,000)
Ending balances (in shares) at Sep. 30, 2021   53,698,840        
Ending balances at Sep. 30, 2021 $ 58,420,000 $ 5,000 444,349,000 0 0 (385,934,000)
Beginning balances (in shares) at Dec. 31, 2021 53,786,632 53,786,632        
Beginning balances at Dec. 31, 2021 $ 32,447,000 $ 5,000 448,969,000 0 0 (416,527,000)
Increase (decrease) in stockholders' equity [Roll Forward]            
Stock-based compensation 10,993,000   10,993,000      
Exercise of warrants (in shares)   600        
Exercise of warrants 7,000   7,000      
Release of restricted stock units (in shares)   567,453        
Cancellation of shares used to settle payroll tax withholding (in shares)   (166,690)        
Cancellation of shares used to settle payroll tax withholding (929,000)   (929,000)      
Issuance of common stock under conversion of Yorkville Note (in shares)   3,393,663        
Issuance of common stock under conversion of Yorkville Note 7,535,000 $ 1,000 7,534,000      
Issuance of common stock under ATM offering (in shares)   12,067,575        
Issuance of common stock under ATM program 29,139,000 $ 1,000 29,138,000      
Issuance of common stock under SEPA (in shares)   3,967,939        
Issuance of common stock under SEPA 4,604,000 $ 1,000 4,603,000      
Commitment fee for SEPA settled by common stock (in shares)   465,117        
Commitment fee for SEPA settled by common stock 1,061,000   1,061,000      
Foreign currency translation adjustment 4,000       4,000  
Net loss $ (173,200,000)         (173,200,000)
Ending balances (in shares) at Sep. 30, 2022 74,082,289 74,082,289        
Ending balances at Sep. 30, 2022 $ (88,339,000) $ 8,000 501,376,000 0 4,000 (589,727,000)
Beginning balances (in shares) at Jun. 30, 2022   58,519,739        
Beginning balances at Jun. 30, 2022 (57,829,000) $ 6,000 461,165,000 0 5,000 (519,005,000)
Increase (decrease) in stockholders' equity [Roll Forward]            
Stock-based compensation 3,616,000   3,616,000      
Exercise of warrants (in shares)   0        
Release of restricted stock units (in shares)   139,846        
Cancellation of shares used to settle payroll tax withholding (in shares)   (38,534)        
Cancellation of shares used to settle payroll tax withholding (77,000)   (77,000)      
Issuance of common stock under conversion of Yorkville Note (in shares)   3,393,663        
Issuance of common stock under conversion of Yorkville Note 7,535,000 $ 1,000 7,534,000      
Issuance of common stock under ATM offering (in shares)   12,067,575        
Issuance of common stock under ATM program 29,139,000 $ 1,000 29,138,000      
Foreign currency translation adjustment (1,000)       (1,000)  
Net loss $ (70,722,000)         (70,722,000)
Ending balances (in shares) at Sep. 30, 2022 74,082,289 74,082,289        
Ending balances at Sep. 30, 2022 $ (88,339,000) $ 8,000 $ 501,376,000 $ 0 $ 4,000 $ (589,727,000)